Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

231.30 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 231.30
Bid (Size) 210.00 (1)
Ask (Size) 242.99 (1)
Prev. Close 231.30
Today's Range 231.30 - 231.30
52wk Range 132.24 - 231.50
Shares Outstanding 146,234,244
Dividend Yield 0.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RxSight Stock Sees Relative Strength Rating Rise To 91
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
Via Investor's Business Daily
Why Quality-Oriented Investors Should Consider NYSE:RMD.
Exploring RESMED INC (NYSE:RMD)'s quality characteristics. 
Via Chartmill

Performance

YTD
+34.65%
+34.65%
1 Month
+11.59%
+11.59%
3 Month
+5.74%
+5.74%
6 Month
+28.03%
+28.03%
1 Year
+39.43%
+39.43%

More News

Read More
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
From ResMed Inc.
Via GlobeNewswire
NYSE:RMD may be ready to breakout.
Via Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Via Benzinga
ResMed's Options Frenzy: What You Need to Know
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
Via Benzinga
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About ResMed
Via Benzinga
Looking Into ResMed's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
Via Benzinga
Is NYSE:RMD a Good Fit for Dividend Investing?
Via Chartmill
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Stock Market News From Amazon, Nike, McCormick, and More
Via The Motley Fool
Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
Via InvestorPlace
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
From ResMed Inc.
Via GlobeNewswire
Beyond The Numbers: 6 Analysts Discuss ResMed Stock
Via Benzinga
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
Via The Motley Fool
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Via MarketBeat
Exposures Product Safety
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why ResMed Shares Are Trading Lower Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.